BNP Paribas Financial Markets’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BNP Paribas Financial Markets’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-14,965	Closed	-$2.59M	–	3754
2015 Q1	$2.59M	Sell	14,965 -384,388	-96%	-$56.4M	0.01%	804
2014 Q4	$45.9M	Buy	399,353 +326,872	+451%	+$39.6M	0.16%	101
2014 Q3	$11.3M	Sell	72,481 -70,853	-49%	-$10.3M	0.01%	466
2014 Q2	$17.7M	Sell	143,334 -41,932	-23%	-$4.63M	0.02%	271
2014 Q1	$20.4M	Buy	185,266 +64,728	+54%	+$6.63M	0.02%	277
2013 Q4	$607M	Sell	120,538 -43,940	-27%	-$3.5M	0.44%	57
2013 Q3	$11M	Sell	164,478 -18,472	-10%	-$1.27M	0.01%	493
2013 Q2	$12.1M	Buy	+182,950	New	+$10.5M	0.01%	310

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets's SLXP Position: Q2 2015 in Review

BNP Paribas Financial Markets sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 14,965 shares — an estimated $2.59M sold.

BNP Paribas Financial Markets first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $607M in Q4 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

BNP Paribas Financial Markets reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
BNP Paribas Financial Markets sold 14,965 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.59M.
BNP Paribas Financial Markets first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
BNP Paribas Financial Markets's SALIX PHARMACEUTICALS LTD DEL position peaked at $607M in Q4 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.